Clinical Trials Browser

Oligometastatic Prostate Cancer × Androgen Antagonists × Clear all

NCT07490210 2026-03-24

OMPC-RPM

Phase 2 Not yet recruiting

Oligometastatic Prostate Cancer

NCT06972511 2025-05-15

Maximal Tumor Eradication for Oligometastatic Prostate Cancer

Phase 2/3 Recruiting

Oligometastatic Prostate Cancer

NCT03940235 2023-06-28

RADIOSA

Phase 2 Unknown

Oligometastatic Prostate Cancer